Headlines about Neuberger Berman High Yield Strateges Fd (NYSE:NHS) have trended somewhat positive on Thursday, Accern Sentiment reports. The research group identifies negative and positive media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Neuberger Berman High Yield Strateges Fd earned a media sentiment score of 0.24 on Accern’s scale. Accern also assigned news stories about the investment management company an impact score of 46.7474880611443 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

Shares of Neuberger Berman High Yield Strateges Fd (NYSE:NHS) opened at 11.88 on Thursday. The stock has a 50 day moving average of $11.93 and a 200 day moving average of $11.92. Neuberger Berman High Yield Strateges Fd has a 12-month low of $10.67 and a 12-month high of $12.21.

The company also recently declared a monthly dividend, which will be paid on Thursday, August 31st. Stockholders of record on Tuesday, August 15th will be issued a dividend of $0.0725 per share. This represents a $0.87 annualized dividend and a dividend yield of 7.32%. The ex-dividend date of this dividend is Friday, August 11th.

TRADEMARK VIOLATION WARNING: This report was originally posted by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are reading this report on another domain, it was illegally stolen and republished in violation of U.S. and international trademark & copyright legislation. The original version of this report can be accessed at https://theolympiareport.com/2017/08/17/somewhat-favorable-media-coverage-somewhat-unlikely-to-affect-neuberger-berman-high-yield-strateges-fd-nhs-share-price.html.

In other news, insider Thomas P. Oreilly sold 14,000 shares of the business’s stock in a transaction dated Wednesday, August 9th. The stock was sold at an average price of $12.08, for a total transaction of $169,120.00. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Thomas P. Oreilly sold 4,000 shares of the business’s stock in a transaction dated Thursday, August 10th. The stock was sold at an average price of $11.83, for a total value of $47,320.00. The disclosure for this sale can be found here.

Neuberger Berman High Yield Strateges Fd Company Profile

Neuberger Berman High Yield Strategies Fund Inc is a non-diversified, closed-end management investment company. The Fund seeks total return (income plus capital appreciation). The Fund normally invests at least 80% of its total assets in high yield debt securities of the United States and foreign issuers, which include securities that are rated below investment grade by a rating agency or are unrated debt securities determined to be of comparable quality by the Fund’s investment manager.

Insider Buying and Selling by Quarter for Neuberger Berman High Yield Strateges Fd (NYSE:NHS)

Receive News & Ratings for Neuberger Berman High Yield Strateges Fd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neuberger Berman High Yield Strateges Fd and related companies with Analyst Ratings Network's FREE daily email newsletter.